Drugs to Watch 2020
Market intelligence reports
BioWorld - Sunday, March 29, 2020
» Phase II clinical trials: February 2020
Looking to read the full article? Subscribe to BioWorld.
Phase II clinical trials: February 2020
March 13, 2020
Therapeutic area data reported by biopharma companies on phase II trials in February 2020, including: Aldeyra, Antibe, Azurrx, Bellerophon, Bioxcel, Brainstorm, Cassava, Cytodyn, Delmar, Dermata, Eisai, Eli Lilly, Fulcrum, Galderma, Galera, Immunicum, Immunogenx, Immutep, Ironwood, Lidds, Magenta, Menlo, Moderna, NGM, Nymox, Oculis, Oncoimmune, Oramed, Palatin, Ra, Reneuron, Roche, Sanofi, T3D, Teva, Theralase, Trovagene, United, Vascular, Vistagen, Zynerba.
Analysis and data insight
Already a subscriber?